Ulrich Keilholz
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Feasibility & Efficacy of Durvalumab+Tremelimumab+RT and Durvalumab+RT in Non-resect. Locally Advanced HPVnegativ HNSCC (NCT03624231) | Ulrich Keilholz | 2018-08-15 |
Track Ulrich Keilholz automatically
Every clearance here is in the API, with alerts when new ones post.